Supplement reference
Cordyceps
A sourced reference on Cordyceps identity, evidence limits and safety context.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
What it is
Cordyceps labels should state species and material, such as Cordyceps sinensis or cultured mycelium. Those products are not automatically interchangeable.
Sources: National Library of Medicine, PubMed
What the cited evidence shows
A 2019 systematic review of 15 studies assessed oral Cordyceps sinensis preparations for stable COPD. It found no placebo-controlled or high-methodological-quality studies, which limits conclusions. It does not support generic energy, endurance or immune claims.
Sources: National Library of Medicine, PubMed
Limits and safety context
This reference does not support using Cordyceps in place of respiratory assessment or prescribed COPD care.
Sources: National Library of Medicine, PubMed
Published sources
- Oral Cordyceps sinensis for stable COPD: systematic review and meta-analysis
National Library of Medicine, PubMed. 2019; accessed 6 September 2026.
Supports: Fifteen studies, none placebo controlled or high methodological quality; not evidence for generic Cordyceps products.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.